Cypress Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Cypress Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,215	Closed	-$242K	–	141
2019 Q2	$242K	Sell	2,215 -200	-8%	-$21.3K	0.08%	130
2019 Q1	$270K	Sell	2,415 -930	-28%	-$102K	0.09%	133
2018 Q4	$323K	Sell	3,345 -1,860	-36%	-$197K	0.12%	124
2018 Q3	$635K	Sell	5,205 -615	-11%	-$72.4K	0.19%	115
2018 Q2	$639K	Sell	5,820 -23,950	-80%	-$2.56M	0.19%	118
2018 Q1	$3.18M	Sell	29,770 -22,050	-43%	-$2.44M	0.93%	38
2017 Q4	$5.53M	Sell	51,820 -3,725	-7%	-$398K	1.19%	27
2017 Q3	$6.18M	Buy	55,545 +5,334	+11%	+$570K	1.33%	20
2017 Q2	$5.19M	Sell	50,211 -5,628	-10%	-$554K	1.06%	33
2017 Q1	$5.46M	Sell	55,839 -1,941	-3%	-$186K	1.04%	32
2016 Q4	$5.11M	Buy	+57,780	New	+$5.26M	0.98%	32

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cypress Asset Management's IBB Position: Q3 2019 in Review

Cypress Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 2,215 shares — an estimated $242K sold.

Cypress Asset Management first reported a position in IBB in Q4 2016 and held it in 11 quarters. The position peaked at $6.18M in Q3 2017. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Cypress Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Cypress Asset Management sold 2,215 iShares Biotechnology ETF shares in Q3 2019, an estimated $242K.
Cypress Asset Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 11 quarters.
Cypress Asset Management's iShares Biotechnology ETF position peaked at $6.18M in Q3 2017.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Cypress Asset Management's 13F filing for Q3 2019, filed 21 Oct 2019.